Archived explainer. For the current picture see today's BHC page.
Why Is BAUSCH HEALTH COS IN (BHC) Stock Up Today?
By the Top Tier Newswire AI Desk · July 31, 2026 at 2:40 PM ET · reviewed against 4 wire stories
BAUSCH HEALTH COS IN (BHC) is up +14.10% in the latest session. Our newswire has captured 4 stories on BHC across 3 sources in the last 36 hours, with AI sentiment reading bullish (avg 65/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
Why BHC stock is up today
Bausch Health Companies Inc. (BHC) surged 14.10% to $6.88 in intraday trading, driven by a better-than-expected Q2 2026 earnings report and an upward revision to its full-year guidance. The stock opened at $6.04 and climbed steadily throughout the session, reaching a high of $6.92 before settling at $6.88. The rally reflects investor optimism over the company's sustained revenue growth and improved profitability.
What Happened
Bausch Health reported its thirteenth consecutive quarter of year-over-year revenue growth, with Q2 consolidated revenues rising 13% to $2.852 billion, surpassing the $2.661 billion estimate. Adjusted earnings per share came in at $1.26, beating the $1.04 estimate. The company also raised its full-year 2026 revenue guidance to a range of $10.790 billion to $11.040 billion, up from $10.670 billion to $10.920 billion. This update reflects continued momentum in its Salix and international segments. The stock's sharp rise followed the release of the earnings call transcript and the updated guidance.
What The Data Shows
The intraday session showed strong buying pressure, with the stock trading at 6.3 times its 3-month daily average volume. The rally pushed BHC to a 52-week high of $6.88, up from a low of $4.33. Despite a market cap of $1.7 billion and a TTM net margin of -11.5%, the stock's recent performance indicates a shift in sentiment. The 30-day average sentiment score improved to 64 out of 100 from 59, signaling growing confidence among market participants.
What To Watch
Investors should monitor the company's upcoming earnings releases and any further updates to its full-year guidance. With continued performance in key segments, Bausch Health may attract more coverage from analysts and institutional investors.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
BHC · Jul 31 session (5-min) · +15.42% vs prior close · updated 8:55 PM ETAI sentiment, last 36h · averaged over 4 stories · 65/100 bullish
The headlines behind the move
Story flow · 3 stories on the wire, last 36h · hover or tap a dot for the headline
11d agoSeeking AlphaBULLISH 73Earnings
Bausch Health posts a record rally after Q2 beat, guidance hike
Bausch Health (BHC) stock surges as the company beats Street forecasts with its Q2 2026 financials and raises its full-year outlook. Read more here.
11d agoMarketChameleonBULLISH 73Earnings
Bausch Health Delivers Double-Digit Revenue Growth and Raises 2026 Guidance After Record Quarter
July 30, 2026
Bausch Health posted its thirteenth straight quarter of year-over-year revenue growth, reported a 13% rise in quarterly consolidated revenues, and raised its full-year 2026 outlook. Highlights include continued earnings momentum, operational execution, and robust cash flow—supported by strong performance across multiple business lines.
11d agoSeeking AlphaNEUTRAL 50Earnings
Bausch Health Companies Inc. (BHC) Q2 2026 Earnings Call Transcript
Bausch Health Companies Inc. (BHC) Q2 2026 Earnings Call July 29, 2026 5:00 PM EDTCompany ParticipantsGaren Sarafian - VP & Head of Investor...
11d agoYahoo TopBULLISH 63Earnings
Bausch Health Cos Q2 Earnings Call Highlights
Bausch Health Cos (NYSE:BHC) reported second-quarter results that management said extended its streak of revenue and adjusted EBITDA growth to 13 consecutive quarters, driven by performance in its Salix, international and Solta Medical businesses. For Bausch Health excluding Bausch + Lomb, second-q
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →